a similar rate of ADHD in children with uncomplicated epilepsy as in the same-age general population was documented. 15 Methods and diagnostic criteria vary widely in studies investigating associations between epilepsy and ADHD, and considerable gaps remain in our knowledge regarding the extent of epileptic seizures (ESz) and epileptic syndromes in children with ADHD. Although ADHD is a common neuropsychiatric diagnosis of childhood, studies on epilepsy among children with ADHD are few 16, [21] [22] [23] and more knowledge is needed about the occurrence and clinical characteristics of epilepsy among children with ADHD. In this paper we study a large sample of children ages 6-14 diagnosed with ADHD, to which degree they also suffer from epilepsy, in order to achieve better understanding of these common comorbid neuropsychiatric disorders. We compared age, sex, disorders of psychological development, cognitive level, pharmacological treatment for ADHD, initial response to treatment and ADHD subtype of children in our cohort with and without epilepsy. In addition, we compared our data with data from a study on the prevalence, classification and severity of epilepsy in children in western Norway. 24 
Methods

Design
This is a retrospective chart-review of children with ADHD.
Material
The medical records of children aged 6-14 years and diagnosed with ADHD between January 2000 and December 2005 at the Department of Child and Adolescent Psychiatry, Stavanger University Hospital, Norway were reviewed. This department is the only Child and Adolescent Psychiatry department in the area, and serves a population of 240,000. All patients in the area with suspected ADHD are referred to the department and it would be reasonable to assume that ADHD sample is population based.
Assessment
A structured clinical interview was used to elicit general and clinical information, including seizures and drug treatment, and a clinical neurological and child psychiatry examination was conducted following a structured guide. In addition, standardized psychiatric instruments including Child Behavior Checklist, 25 Conners Parent/Teacher rating scale, 26 and ADHD rating scale IV 27 were administered in all children. On the basis of the clinical interview and the diagnostic procedures, ADHD and subtypes were diagnosed according to DSM-IV-TR. 1 The majority of patients (549; 90.4%) went through the Wechsler Intelligence Scale-Revised (WISC-R) for intelligence assessment 28 and patients with IQ below 50 and those meeting criteria for pervasive developmental disorder were excluded from the present study. As part of the routine assessment, digitized 20 min routine EEG with 21 electrodes (10-20 system) was conducted in 517 of the children with ADHD, including hyperventilation and photic stimulation during wakefulness without sleep deprivation. 
Statistical analysis
Demographic and clinical variables in subjects with and without epileptic seizures were compared using Student's t-test for continuous and normally distributed data, and nonparametric tests for categorical or non-normally distributed data. A p-value of <0.05 was considered statistically significant. The study was approved by the Norwegian Data Inspectorate and by the Regional Committee on Medical Research Ethics in region West (nr. 010.07).
Results
A total of 607 children (82.4% males) aged 6-14 years with ADHD were identified. Of these 14 (2.3%) had a history of epilepsy and 13 of these had active epilepsy. This is a significantly higher occurrence than previously reported in a Norwegian general pediatric population in which 0.5% (198 of 38,593) of children between 6 and 12 years had epilepsy (p < 0.0001). 24 The patients with epilepsy did not differ from the patients without epilepsy with respect to age, gender, disorders of psychological development, IQ level < 85 or ADHD subtype, respectively (Table 1) . These children had been diagnosed with epilepsy on average 1.8 years before the ADHD assessment. The clinical characteristics of the children with ADHD and a history of epilepsy are summarized in Table 2 . Eleven (78.6%) of the children had been seizure-free for at least one year before ADHD assessment. Two of the children had 1-12 seizures per year, and one had >12 seizures per year. Two of the children, both seizure-free patients, were not treated with an AED. Ten children were on AED monotherapy; valproate (VPA) in 3 patients, carbamazepine (CBZ) in two, oxcarbazepine (OXC) in two, lamotrigine (LTG) in one, levetiracetam (LEV) in one and sulthiame (SUL) in one. Two patients were on polytherapy. One child with symptomatic epilepsy (hypothalamic tumor) was treated with combination of LTG and topiramate (TPM), and a second case (cryptogenic etiology) with TPM and ethosuximide (ESM). None of our patients were treated with phenobarbital (PB) or phenytoin (PHT). Of the 14 patients with a history of epilepsy, 11 (78.6%) had focal seizures, seven also had secondary generalized tonic-clonic seizures and three patients had only primary generalized seizures. Localization-related epilepsies were more common (10 cases) than generalized epilepsies (3 cases).
Benign childhood epilepsy with centrotemporal spikes (BCECTS) was found in two cases and childhood absence epilepsy (CAE) in two cases. The seizure types and etiologies of the epilepsy are described for each patient in Table 2 . Methylphenidate was the pharmacological treatment for ADHD in all 14 children with a history of seizures and initial response to methylphenidate was achieved in 12 (85.7%).
Discussion
This study investigated the prevalence and characteristics of epilepsy in, to the authors' knowledge, the largest unselected cohort of children with ADHD, and the findings add to the extant clinical understanding of their relationships. The main finding in this study was that 14 children (2.3%) of our cases (N = 607) with ADHD had history of epilepsy and 13 of these had active epilepsy. This rate of occurrence of active epilepsy was higher than would be expected from epidemiological studies in pediatric populations (0.4-1%).
2 Two studies from Norway have reported a similar prevalence of active epilepsy in the general pediatric population; 0.4% in the age group 0-14 years, 33 and 0.5% (198 of 38,593) between 6 and 12 years. 24 The study from western Norway 24 reported that symptomatic etiology was diagnosed in 46.7%, idiopathic in 28.8% and cryptogenic in 24.7%, and seizure freedom was achieved in 30.8% of the children. However, our findings differ, with symptomatic etiology in 14.3%, idiopathic in 35.7% and cryptogenic in 42.9%, and freedom from seizures was achieved in 78.6%. Our results suggest that the majority of patients with epilepsy and ADHD diagnosed in our child psychiatric department had mild (an easily treated) epilepsy and were seizure free. This is in contrast to the results from epidemiological studies in pediatric population. 24, 33, 34 Seizure types/epileptic syndromes in our study were more often partial/localization related than generalized similar to the findings in the Norwegian prevalence study. 24 BCECTS, an epileptic syndrome commonly occurring in school children, was diagnosed in two cases in our study. One study from Germany has reported an association between ADHD, rolandic spikes and BCECTS, 35 and another study has also reported that children with BCECTS exhibited attention problems and aggressive behavior more frequently than healthy controls. 36 Among our three children with idiopathic generalized epilepsy, two had the syndrome of childhood absence epilepsy (CAE) and one case had epilepsy with grand mal on awakening (EGMA). An association between CAE and ADHD has been previously reported. 20 Landau-Kleffner syndrome (LKS) is a relatively rare epilepsy syndrome; we identified one patient with this syndrome even though we had a small sample. It is usual for boys to predominate amongst children with ADHD, 1 and this was also found in our study. However, amongst those with epilepsy, the relative proportion of girls was high (28.6% versus 17.4% of those without epilepsy). An equal male: female ratio has been reported in studies on epilepsy patients with ADHD.
7,12,37 
Epilepsy in children with ADHD
Studies on epilepsy in children diagnosed with ADHD are few, and two of them had small samples of ADHD patients i.e. 68 and 28. 22, 23 The largest study that we identified included 130 patients with ADHD, 21 and reported a higher occurrence of epilepsy (2%) than expected in the general population (1%). However, only 3 patients had previous histories of epilepsy. All three children had developmental delays and one was diagnosed with autism one year after inclusion. The authors suggested that these comorbid conditions might place them at a much higher risk of epilepsy. Disorders of psychological development were also common in our patients (60.5%) ( Table 2 ), but this proportion was not significantly higher among those with epilepsy than those without epilepsy. In addition we analyzed influence of IQ level. It is expected that children with IQ < 85 are more likely to have epilepsy. 38 However, our ADHD patients with and without epilepsy did not differ regarding to IQ < 85 (p = 0.48), thus supporting an association between epilepsy and ADHD, independent of lower IQ level. A recent study 16 compared the incidence and characteristics of epilepsy among children with (n = 358) and without ADHD (n = 728). In contrast to other studies whose subjects were already clinically diagnosed ADHD patients, [21] [22] [23] in this large study the diagnosis of ADHD was not made in a clinical setting but were based on retrospective review of school reports and medical records until age of 20. Consequently, it may appear uncertain whether all the included patients actually suffered from ADHD. Epilepsy was found to occur in 2.2% (8 of 358) of those with ADHD, compared with 0.8% (6 of 728) in those without ADHD, representing a 2.7-fold greater incidence of epilepsy among children with ADHD than in controls. In children with ADHD, epilepsy appeared to have an earlier onset, was of greater severity and was less likely to respond to AED treatments. Phenobarbital (PB) was used in 5 (63%) of their patients and in all cases PB was stopped prior to the diagnosis of ADHD. Among children with ADHD symptoms, those with epilepsy were less likely to receive a clinical diagnosis and treatment of ADHD than those without epilepsy, possibly reflecting a reluctance to diagnose and treat ADHD symptoms in children with epilepsy. In contrast to these results, in our study, all patients diagnosed with epilepsy received medical treatment (methylphenidate) for ADHD, and epilepsy comorbidity was apparently not considered as a reason for not treating ADHD. The majority of our patients had mild (an easily treated) epilepsy and AED treatment was successful. Of antiepileptic drugs which are particularly recognized to have cognitive and behavioral side effects that may resemble symptoms of ADHD (barbiturates, benzodiazepines and LEV), 39 among our patients LEV was monotherapy in one patient, but none of our patients was treated with PB or a benzodiazepine.
ADHD subtype and epilepsy
Several studies have reported that the ADHD-I subtype was more common in children with epilepsy, 7, 12, 18, 37, 40, 41 and in cases with epileptiform EEG abnormalities 42 than in children with ADHD alone. One population based case control study of newly diagnosed unprovoked seizures among Icelandic children younger than 16 years, reported that they were 2.5-fold more likely than age-and sex-matched controls to have a parent-reported history of ADHD-I before seizure onset. 41 Another study involving tertiary care samples of 175 children with epilepsy without significant developmental delays who had at least a 6 months history of epilepsy found that children with epilepsy were at higher risk for symptoms of ADHD than the general population. 7 They differed from the other samples of children with ADHD by having a larger proportion of children with ADHD-I and by equal incidence in males and females. It might be important to note that 71.4% children in our sample with epilepsy and ADHD had ADHD-C, a figure that differs from studies of ADHD in epilepsy samples that found more than 50% of children had ADHD-I. 7 Different results may be explained by selection of patients. Our results represent the child psychiatry population (ADHD patients with epilepsy) which usually has combined type of ADHD more often than inattentive type of ADHD. There are many possible explanations for an association between ADHD and epilepsy. Patients with epilepsy and ADHD may have many factors that influence occurrence of the ADHD-I, for example, subtle epileptic seizures, transient effects of frequent epileptiform discharges, antiepileptic treatment and underlying neurodevelopmental vulnerability. It is interesting to note that all our patients had already been diagnosed with epilepsy before they were diagnosed with ADHD. Those with epilepsy tended to have a younger age at ADHD assessment than those without epilepsy (8.2 vs. 9.4 years). None of the children were being treated with PB or benzodiazepines which could mimic ADHD symptoms, suggesting that neurodevelopmental vulnerability and epilepsy diagnosis with its complexity might contribute to the variation and determination in ADHD subtype. This finding supports that after the diagnosis of epilepsy, ADHD symptoms or ADHD may occur with a greater frequency than expected. It would be interesting to find out if ADHD patients without previous history of epilepsy (with and without epileptiform abnormalities) have increased risk for epileptic seizures occurrence during follow-up and this question should be investigated in further studies. An increased risk for epileptic seizures has also been reported among pediatric patients with psychiatric diagnoses other than ADHD. 43 However, for children with ADHD, particular attention is warranted. ADHD symptoms may precede, occur simultaneously with, or occur subsequent to a diagnosis of epilepsy. From a clinical perspective, it is important to be able to differentiate between the onsets of epilepsy and ADHD, and to be able to determine whether a patient with both conditions should receive AED treatment or pharmacological treatment for ADHD, or both, and on what time scale. In our study we identified three patients who were assessed for epilepsy and for ADHD simultaneously. From the information available at assessment, it was not obvious whether they actually suffered from ADHD or whether their symptoms originated from unrecognized ESz (staring, complex partial seizures, absences). After careful assessment, and following diagnosis of epilepsy, these children were also diagnosed with ADHD. Our results highlight the need for carefully assessment of children with ADHD, especially those with ADHD-I. The differential diagnosis of epilepsy vs. ADHD might be difficult, but it is important to recognize that they are not mutually exclusive. Research directed toward identifying the clinical course of epilepsy and ADHD symptoms in children with both conditions could provide information of clinical significance. It could allow better assessment and evaluation, and reduce medical overtreatment of these common neuropsychiatric disorders.
Limitations and strengths of study
Our study has a retrospective, cross-sectional design, and thus there is a risk that epilepsy was under-diagnosed. However, influence of co-morbid disorders was considered regarding developmental delays and cognitive level, and patients with autism spectrum disorder and IQ < 50 were excluded. Strengths include the relatively large and unselected cohort, as all children with suspected ADHD were referred to the center and were clinically diagnosed with ADHD although the number of children with epilepsy was small.
We found no statistically significant difference between groups on any characteristic, only trends. This could be type II errors due to small sample size.
Conclusions
The epilepsy diagnosis preceded the ADHD diagnosis in all patients, and was found in 2.3% which is significantly higher than would be expected in the general pediatric population. The majority of patients had mild epilepsy and ADHD-C. All cases with epilepsy were treated with MPH, with initial response achieved in 86%.
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